GREAT EMPLOYEES ARE LEAVING IN DROVES - Avis employé Employé (anonyme) TransMedics

1,0
19 avr. 2019
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Product will revolutionize the face or organ transplant. It is exciting to work for this company knowing that your contribution has a direct effect on this breakthrough technology.

Inconvénients

Over the last several years the CEO has been distanced from the day to day operations and day-to-day management is left to Senior VP's who have been with the company for a long time and are stagnant to growth and improvement. Salary increases are rare. You will have additional duties piled on to your plate until they burn you out. Over the last 6 months, key, longstanding employees have left! This is not a financially stable company. Trouble getting parts in-house because Suppliers have placed the company on credit hold. There is no 401k matching. There is no collaborative teamwork but there is a lot of finger pointing when problems arise. Zero opportunity for career advancement.

Découvrez plus d’avis sur TransMedics

5,0
1 juil. 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

The work you do really makes a difference everyday. Good pay, good benefits

Inconvénients

You need to live in Boston

1,0
25 juin 2026
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Some passionate people who work hard You can make a big impact because the company is small but you will need to set boundaries hard and fast.

Inconvénients

-Pay lags behind industry -Relocation details arent clear -HR stymie's career growth -Chaotic organization with conflicting goals and timelines -Many burnt out folks -Some in senior leadership dont listen to those below them. There is significant burn out in manufacturing due to unending overtime and continuous weekend overtime, with no end in sight. -looking back if i could talk to myself before starting here I would talk myself out of it.

1
Voir les avis par: Utile|Évaluation|Date|Tout